Related Experiment Videos
Falsely elevated human chorionic gonadotropin leading to unnecessary therapy
T G Olsen1, P R Hubert, L R Nycum
1David Grant Medical Center, Travis Air Force Base, California, USA. tandyolsen@hotmail.com
Obstetrics and Gynecology
|November 13, 2001
Summary
Serum human chorionic gonadotropin (beta-hCG) analysis is crucial for pregnancy management. Incongruent results between serum and urine beta-hCG tests warrant further investigation to ensure accurate diagnosis.
Area of Science:
- Reproductive endocrinology
- Clinical chemistry
- Gynecology
Background:
- Serum beta-hCG is a key biomarker for diagnosing and managing pregnancies and related conditions.
- Elevated beta-hCG levels are typically specific to trophoblastic tissue, making them highly reliable indicators.
- Accurate beta-hCG measurement is vital for differentiating intrauterine pregnancies, ectopic gestations, and gestational trophoblastic neoplasia.
Observation:
- Two cases presented with clinical histories inconsistent with serum beta-hCG findings.
- Despite negative ultrasound and passage of tissue, serum beta-hCG remained elevated in one patient.
- Persistent elevated serum beta-hCG, even after curettage and methotrexate, contrasted with negative urine tests in both cases.
Findings:
- Serum beta-hCG assays may yield false-positive results in specific clinical scenarios.
- Urine beta-hCG testing can serve as a crucial confirmatory or discrepant analysis tool.
- Discrepancies between serum and urine beta-hCG necessitate careful clinical correlation and further diagnostic evaluation.
Implications:
- Clinicians should consider urine beta-hCG testing when serum results appear incongruent with patient presentation.
- This approach can help prevent misdiagnosis and guide appropriate management in complex gynecological cases.
- Integrating multiple testing methods enhances diagnostic accuracy in reproductive health assessments.